Results of a Clinical Study of Pevonedistat (Pev),a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Swords, RT; Coutre, S; Maris, MB; Zeidner, JF; Foran, JM; Cruz, JC; Erba, HP; Berdeja, JG; Tam, W; Vardhanabhuti, S; Dobler, I; Faessel, HM; Dash, AB; Sedarati, F; Dezube, BJ; Savona, MR

Published Date

  • December 2, 2016

Published In

Volume / Issue

  • 128 / 22

Published By

Pages

  • 8

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 3, 2016

Conference End Date

  • December 6, 2016